Castle Biosciences Inc. (CSTL) Earnings
|
Expand Research on CSTL
| Next EPS Date | 8/10/26 | EPS Growth Rate | -366.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +75.1% | Revenue Growth Rate | +0.1% |
| Average % Move 1-Wk after EPS | +4.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q226 | N/A | -$0.40 | N/A | N/A | $86.26M | N/A | N/A | N/A | ||
| 5/6/26 | Q126 | -$0.49 | -$0.49 | $0.00 | $83.7M | $77.46M | N/A |  | | Details | |
| 2/26/26 | Q425 | -$0.08 | -$0.32 | +$0.24 | $87M | $77.09M | N/A | | | Details | |
| 11/3/25 | Q325 | -$0.02 | -$0.52 | +$0.50 | $83M | $71.03M | = | | | Details | |
| 8/4/25 | Q225 | $0.15 | -$0.51 | +$0.66 | $86.19M | $71.43M | = | | | Details | |
| 5/5/25 | Q125 | -$0.20 | -$0.06 | -$0.14 | $88M | $80.58M | = | | | Details | |
| 2/27/25 | Q424 | $0.32 | $0.01 | +$0.31 | $86.31M | $80.54M | = | | | Details | |
| 11/4/24 | Q324 | $0.08 | $0.00 | +$0.08 | $86M | $79.85M | = | | | Details |
